BioSpace News Archive

Intercept Pharmaceuticals, Inc., a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, announced the appointment of Dagmar Rosa-Bjorkeson to its Board of Directors as of April 1, 2021.

Jounce Therapeutics, Inc., a clinical-stage company focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers, announced that Jounce management will present at several upcoming investor conferences

Krystal Biotech Inc. , (“Krystal”) (NASDAQ: KRYS), the leader in redosable gene therapies for rare diseases, today announced that Krish S. Krishnan, Chairman and Chief Executive Officer will be participating in a fireside chat at the 41 st Annual Cowen Health Care Conference taking place March 1-4, 2021.

Meridian Bioscience, Inc., a provider of diagnostic testing solutions and life science raw materials, provided a further update on its application for Emergency Use Authorization with the U.S. Food and Drug Administration for the SARS-CoV-2 molecular diagnostic test on its Revogene® platform.

Reflect Scientific, Inc., a provider of diverse products and services for biotechnology, pharmaceutical, and transportation industries, announces a 23.7% year over year fourth quarter increase in sales.

Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced that it has signed a collaboration agreement with Vanderbilt University.

- Strong execution across pipeline of immune-modulating assets throughout 2020 enables multiple milestones in 2021 - - Rilonacept in recurrent pericarditis granted priority review, with PDUFA goal date of March 21, 2021 - - Clinical data expected in 1H 2021 from KPL-404 (anti-CD40) Phase 1 clinical trial and mavrilimumab Phase 2 clinical trial in severe COVID-19 - - Year-end 2020 cash reserves of approximately $323 million

PMV Pharmaceuticals, Inc. (Nasdaq: PMVP), a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies targeting p53 mutants, today announced that David H. Mack, Ph.D., President & Chief Executive Officer, will participate in the Lung Cancer Panel at the Cowen 41 st Annual Health Care Conference taking place virtually on March 1-4, 2021.

Neuronetics, Inc. announced that clinical data from NeuroStar Outcomes Registry comparing outcomes with NeuroStar’s Standard TMS protocol and its shorter, Dash protocol has been published in Brain Stimulation and is available online now.

Evofem Biosciences, Inc., (NASDAQ: EVFM) today announced it will present at the upcoming H.C. Wainwright Global Life Sciences Conference. Evofem’s CEO, Saundra Pelletier , will provide an update on the commercialization of its non-hormonal, use-it-only-when-you-need-it birth control method,